Laxabixal

Bisacodyl, the active ingredient in Laxabixal, is a stimulant laxative presented as an oral tablet for oral use. It is used to relieve occasional constipation in adults and children when appropriate.

GNH USA supplies Laxabixal as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Bisacodyl acts on the lower gastrointestinal tract to alleviate constipation.

- Constipation: provides relief of occasional constipation by stimulating bowel movements.

Bisacodyl may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Abdominal cramps - Diarrhea - Nausea - Urgency to defecate - Flatulence - Abdominal pain

Serious or Rare Side Effects: - Severe dehydration - Electrolyte imbalance (e.g., hypokalemia) - Allergic reaction (rash, itching, swelling) - Rectal bleeding - Persistent abdominal pain - Severe abdominal distension

Use Bisacodyl only as directed and consider patient-specific factors before initiating therapy.

- Chronic use: avoid prolonged daily use to prevent dependence - Intestinal obstruction: contraindicated in known obstruction - Elderly patients: use lower doses and monitor for dehydration - Dehydration risk: ensure adequate fluid intake - Electrolyte monitoring: watch for imbalances in susceptible individuals - Store at ambient temperature: keep in original container, protect from moisture.

Bisacodyl can interact with other medicines, affecting efficacy or safety.

Major Interactions (Avoid): - Anticholinergic agents: may reduce laxative effect - Loop diuretics: increased risk of electrolyte disturbances

Moderate Interactions (Monitor Closely): - Antacids: may alter absorption of bisacodyl - Warfarin: potential impact on INR, monitor coagulation - Thyroid hormone replacement: possible alteration of absorption - Magnesium-containing products: additive laxative effect